PLoS One. 2022 Dec 6;17(12):e0276773. doi: 10.1371/journal.pone.0276773. eCollection 2022.
NO ABSTRACT
PMID:36472969 | DOI:10.1371/journal.pone.0276773
Categories
An efficacy and safety report based on randomized controlled single-blinded multi-centre clinical trial of ZingiVir-H, a novel herbo-mineral formulation designed as an add-on therapy in adult patients with mild to moderate COVID-19
